Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions

被引:45
作者
Kramer, BC
Mytilineou, C
机构
[1] CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
来源
JOURNAL OF NEUROCYTOLOGY | 2004年 / 33卷 / 02期
关键词
D O I
10.1023/B:NEUR.0000030696.62829.ec
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
The proteins of the bcl-2 family play an important role during apoptosis and may also regulate cell death in response to oxidative stress, which has been implicated in Parkinson's disease. In this study we examined the localization of the pro-apoptotic protein bax, and the anti-apoptotic proteins bcl-2 and bcl-x(L) in the substantia nigra (SN) of the adult rat and their response to oxidative stress caused by striatal injections of 6-hydroxydopamine (6-OHDA). Our data show that bcl-2, bcl-x and bax proteins are present in the SN. Bcl-2 and bax are localized primarily in neurons including all those positive for tyrosine hydroxylase (TH). The intraneuronal distribution of bcl-2 and bax were different. Bcl-2 was diffuse throughout the cell while bax was localized in well-defined structures around the nucleus and within processes. Bcl-x staining in neurons was weak, though it was strongly expressed in GFAP-positive astrocytes. 6-OHDA injections, which resulted in loss of dopamine neurons between 7-14 days post-lesion, altered the distribution of bax, bcl-2 and bcl-x proteins in the SN. Bcl-2 and bax were decreased in the TH-positive cells of the SN from 3 to 14 days post-lesion and many TH-positive neurons were bcl-2 negative. Neuronal bcl-x was initially unchanged after lesion, but increased in astrocytes between 3-7 days post-lesion before the increase in GFAP immunoreactivity, which was detectable at days 10-14. While the neuronal distribution of bcl-2 and bcl-x does not change following lesion, bax became evenly distributed thought the soma. Morphological features of apoptosis, including TUNEL labeling and chromatin condensation was not observed. These data suggest that striatal 6-OHDA lesions do not result in classical apoptosis in the SN of the adult rat, even though there are changes in the content and distribution of members of the bcl-2 family of proteins.
引用
收藏
页码:213 / 223
页数:11
相关论文
共 44 条
[1]
BCL-2 GENE IS HIGHLY EXPRESSED DURING NEUROGENESIS IN THE CENTRAL-NERVOUS-SYSTEM [J].
ABEDOHMAE, S ;
HARADA, N ;
YAMADA, K ;
TANAKA, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) :915-921
[2]
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
[3]
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[4]
BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]
Bruce-Keller AJ, 1998, J NEUROCHEM, V70, P31
[6]
BCL-2 MESSENGER-RNA IS LOCALIZED IN NEURONS OF THE DEVELOPING AND ADULT-RAT BRAIN [J].
CASTREN, E ;
OHGA, Y ;
BERZAGHI, MP ;
TZIMAGIORGIS, G ;
THOENEN, H ;
LINDHOLM, D .
NEUROSCIENCE, 1994, 61 (01) :165-177
[7]
INDUCTION OF APOPTOSIS BY THE BCL-2 HOMOLOG BAK [J].
CHITTENDEN, T ;
HARRINGTON, EA ;
OCONNOR, R ;
FLEMINGTON, C ;
LUTZ, RJ ;
EVAN, GI ;
GUILD, BC .
NATURE, 1995, 374 (6524) :733-736
[8]
BAX is required for neuronal death after trophic factor deprivation and during development [J].
Deckwerth, TL ;
Elliott, JL ;
Knudson, CM ;
Johnson, EM ;
Snider, WD ;
Korsmeyer, SJ .
NEURON, 1996, 17 (03) :401-411
[9]
INCREASED LEVELS OF LIPID HYDROPEROXIDES IN THE PARKINSONIAN SUBSTANTIA-NIGRA - AN HPLC AND ESR STUDY [J].
DEXTER, DT ;
HOLLEY, AE ;
FLITTER, WD ;
SLATER, TF ;
WELLS, FR ;
DANIEL, SE ;
LEES, AJ ;
JENNER, P ;
MARSDEN, CD .
MOVEMENT DISORDERS, 1994, 9 (01) :92-97
[10]
BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389